Form 8-K - Current report:
SEC Accession No. 0001104659-25-109119
Filing Date
2025-11-10
Accepted
2025-11-10 16:01:26
Documents
14
Period of Report
2025-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K capr-20251110x8k.htm   iXBRL 8-K 38570
2 EX-99.1 capr-20251110xex99d1.htm EX-99.1 160637
3 GRAPHIC capr-20251110xex99d1001.jpg GRAPHIC 5626
  Complete submission text file 0001104659-25-109119.txt   329458

Data Files

Seq Description Document Type Size
4 EX-101.SCH capr-20251110.xsd EX-101.SCH 2669
5 EX-101.LAB capr-20251110_lab.xml EX-101.LAB 15265
6 EX-101.PRE capr-20251110_pre.xml EX-101.PRE 9653
16 EXTRACTED XBRL INSTANCE DOCUMENT capr-20251110x8k_htm.xml XML 4728
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 251466023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)